Loading...

477 posters, 14 topics, 2,065 authors, 1,055 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

The Joint EBJIS-MSIS 2026 Conference

17 - 19 September, 2026 | Porto, Portugal

The Joint EBJIS-MSIS 2026 Conference banner

EP449

Spinal vs General Anesthesia on the Risk of Surgical Site and Periprosthetic Joint Infections: A Systematic Review and Meta Analysis

Part of Topic

Prosthetic Joint Infections

General Versus Neuraxial Anesthesia and Infection Risk in Total Knee and Hip Arthroplasty: A Systematic Review and Meta-Analysis
Kyle Cantave, BA1; Reginald Chinweze M.D., LLM2; Andrew Cole Ringo Foster, BS1; David Dallas-Orr, MD, MBA, MTM2; Zachary Lum, DO2

1. University of California Davis, School of Medicine, Sacramento, CA, USA 
2. Department of Orthopaedic Surgery, University of California Davis, Sacramento, CA, USA 

 

Introduction

▪Surgical site infection (SSI) and periprosthetic joint infection (PJI) are debilitating complications of TKA and THA.
▪General anesthesia (GA) has been implicated as a risk factor for SSI/PJI.
▪Objective: to examine the association between anesthesia type and the risk of SSI and PJI on patients undergoing TKA and THA.  

Methods

▪PRISMA-guided systematic review and meta-analysis.
▪Comparative studies of adult THA/TKA patients receiving GA vs. neuraxial anesthesia, reporting SSI and/or PJI.

Results

▪25 studies met inclusion criteria (24 SSI datasets; 3 PJI datasets).
▪SSI: directionally higher, statistically non-significant odds with GA; substantial heterogeneity.
▪PJI: no significant difference between anesthesia types; negligible heterogeneity.
 

Discussion

▪No significant infection difference: GA showed higher SSI odds than neuraxial, but not statistically significant.
▪ PJI data too sparse for firm conclusions.
▪High heterogeneity limits certainty: Inconsistent SSI/PJI definitions, short follow-up (30–90 days), and confounding by indication (GA often used in higher-risk patients) weaken the signal.
▪Implications: Anesthetic choice should stay individualized, not infection-driven.
▪Future studies need standardized endpoints, longer follow-up, and better confounder adjustment.
•
ebjis-msis2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.